Now showing items 1-6 of 6

    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-03-05)
      The present embodiment of the invention is generally directed to compositions comprising suspensions of poorly water soluble compounds recrystallized in nanoparticulate sizes ranging from 0.1 to 5 ?m. In addition, the ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-05-04)
      Disclosed are methods and compositions for the treatment of a wide array of cancers and tumors. In illustrative embodiments, diindolylmethanes, C-substituted diindolylmethanes, and analogs thereof have been described, which ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2000-10-24)
      Methods and pharmaceutical combinations for inhibiting estrogen-dependent tumors via the co-administration of antiestrogen triphenylethylenes, including tamoxifen, and alkyl PCDFs.
    • Safe, Stephen H.; Chintharlapalli, Sudhakar; Mcalees, Alan; Mccrindle, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-03-05)
      The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1999-09-07)
      Provided in the present invention are compounds and compositions of substituted indole-3-carbinols and diindolylmethane suitable for treating estrogen-dependent tumors. Also provided are methods of treating such ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1996-05-14)
      Provided is a method of inhibiting estrogen activity by administering a biologically active amount of a substituted dibenzofuran or substituted dibenzodioxin.